Search Results
Dec 23, 2025, 15:30 ET QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm
NASDAQ: QURE) ("uniQure").
More news about: Kessler Topaz Meltzer & Check, LLP
Dec 16, 2025, 20:53 ET QURE Investigation Notice: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm
NASDAQ: QURE) ("uniQure").
More news about: Kessler Topaz Meltzer & Check, LLP
Dec 10, 2025, 17:38 ET QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm
NASDAQ: QURE) ("uniQure").
More news about: Kessler Topaz Meltzer & Check, LLP
Dec 07, 2025, 12:01 ET Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years
(NCT05962398), which will track patients for up to 15 years post-treatment.The multi-year clinical development of HEMGENIX was led by uniQure (Nasdaq: QURE) and sponsorship of the clinical trials transitioned to CSL after it licensed global rights to commercialize the treatment. CSL also established a post-marketing
More news about: CSL
Dec 04, 2025, 16:48 ET QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm
NASDAQ: QURE) ("uniQure").
More news about: Kessler Topaz Meltzer & Check, LLP
Dec 02, 2025, 07:11 ET TrustCommerce® and Qure4u Join Forces to Streamline and Secure Integrated Patient Payments Across the Healthcare Continuum
transactions are PCI DSS compliant and secure.About Qure4uQure4u's all-in-one AI platform automates the entire patient journey—from scheduling and check-in to payments and follow-up—turning engagement into measurable revenue. Qure4u reports strong adoption and performance metrics, including
More news about: TrustCommerce, a Sphere Company
Nov 28, 2025, 11:46 ET QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm
NASDAQ: QURE) ("uniQure").
More news about: Kessler Topaz Meltzer & Check, LLP
Nov 22, 2025, 11:40 ET QURE Investigation Notification: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm
NASDAQ: QURE) ("uniQure").
More news about: Kessler Topaz Meltzer & Check, LLP
Nov 20, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of uniQure N.V. - QURE
20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of uniQure N.V. ("uniQure" or the "Company") (NASDAQ: QURE). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Nov 14, 2025, 04:17 ET uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - QURE
QURE) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether
More news about: DJS Law Group LLP
Nov 11, 2025, 04:40 ET QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm
QURE) for violations of the securities laws.
More news about: The Schall Law Firm
Nov 11, 2025, 04:23 ET uniQure N.V. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - QURE
QURE) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether
More news about: DJS Law Group LLP
Nov 10, 2025, 20:30 ET QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm
NASDAQ: QURE) ("uniQure").
More news about: Kessler Topaz Meltzer & Check, LLP
Sep 25, 2025, 09:15 ET Healthcare Innovation Accelerates as Four Converging Forces Drive Early Intervention Focus
and personalized medicine for significant growth opportunities through Avant Technologies, Inc. (OTCQB: AVAI), uniQure N.V. (NASDAQ: QURE), Veracyte, Inc. (NASDAQ: VCYT), Humana Inc. (NYSE: HUM), and Editas Medicine, Inc. (NASDAQ: EDIT).
More news about: USA News Group
Sep 18, 2025, 09:10 ET Anti-Aging Biotech Surges as $101M Competition Ignites Global Race Against Aging Demographics
(NASDAQ: HCWB), Solid Biosciences Inc. (NASDAQ: SLDB), ProMIS Neuorsciences, Inc. (NASDAQ: PMN), and uniQure N.V. (NASDAQ: QURE).
More news about: USA News Group